DARE
Price
$2.90
Change
-$0.04 (-1.37%)
Updated
Apr 4, 04:53 PM (EDT)
Capitalization
25.58M
HOOK
Price
$0.82
Change
-$0.03 (-3.53%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
10.26M
Ad is loading...

DARE vs HOOK

Header iconDARE vs HOOK Comparison
Open Charts DARE vs HOOKBanner chart's image
Dare Bioscience
Price$2.90
Change-$0.04 (-1.37%)
Volume$150
Capitalization25.58M
HOOKIPA Pharma
Price$0.82
Change-$0.03 (-3.53%)
Volume$2.03K
Capitalization10.26M
DARE vs HOOK Comparison Chart
Loading...
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DARE vs. HOOK commentary
Apr 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DARE is a Hold and HOOK is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 06, 2025
Stock price -- (DARE: $2.93 vs. HOOK: $0.85)
Brand notoriety: DARE and HOOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DARE: 44% vs. HOOK: 197%
Market capitalization -- DARE: $25.58M vs. HOOK: $10.26M
DARE [@Biotechnology] is valued at $25.58M. HOOK’s [@Biotechnology] market capitalization is $10.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DARE’s FA Score shows that 0 FA rating(s) are green whileHOOK’s FA Score has 1 green FA rating(s).

  • DARE’s FA Score: 0 green, 5 red.
  • HOOK’s FA Score: 1 green, 4 red.
According to our system of comparison, HOOK is a better buy in the long-term than DARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DARE’s TA Score shows that 4 TA indicator(s) are bullish while HOOK’s TA Score has 5 bullish TA indicator(s).

  • DARE’s TA Score: 4 bullish, 3 bearish.
  • HOOK’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, HOOK is a better buy in the short-term than DARE.

Price Growth

DARE (@Biotechnology) experienced а +1.38% price change this week, while HOOK (@Biotechnology) price change was -29.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.75%. For the same industry, the average monthly price growth was -16.58%, and the average quarterly price growth was -18.37%.

Reported Earning Dates

DARE is expected to report earnings on Aug 08, 2024.

HOOK is expected to report earnings on Nov 13, 2024.

Industries' Descriptions

@Biotechnology (-10.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DARE($25.6M) has a higher market cap than HOOK($10.3M). DARE YTD gains are higher at: -6.090 vs. HOOK (-57.687). DARE has higher annual earnings (EBITDA): -23.19M vs. HOOK (-40.85M). HOOK has more cash in the bank: 39.7M vs. DARE (11.2M). HOOK has less debt than DARE: HOOK (875K) vs DARE (1.4M). HOOK has higher revenues than DARE: HOOK (43.9M) vs DARE (1.88M).
DAREHOOKDARE / HOOK
Capitalization25.6M10.3M249%
EBITDA-23.19M-40.85M57%
Gain YTD-6.090-57.68711%
P/E Ratio0.10N/A-
Revenue1.88M43.9M4%
Total Cash11.2M39.7M28%
Total Debt1.4M875K160%
FUNDAMENTALS RATINGS
DARE vs HOOK: Fundamental Ratings
DARE
HOOK
OUTLOOK RATING
1..100
751
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
10
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
7996
P/E GROWTH RATING
1..100
75100
SEASONALITY SCORE
1..100
n/a17

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HOOK's Valuation (10) in the Pharmaceuticals Major industry is somewhat better than the same rating for DARE (69) in the Biotechnology industry. This means that HOOK’s stock grew somewhat faster than DARE’s over the last 12 months.

HOOK's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as DARE (100) in the Biotechnology industry. This means that HOOK’s stock grew similarly to DARE’s over the last 12 months.

HOOK's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as DARE (100) in the Biotechnology industry. This means that HOOK’s stock grew similarly to DARE’s over the last 12 months.

DARE's Price Growth Rating (79) in the Biotechnology industry is in the same range as HOOK (96) in the Pharmaceuticals Major industry. This means that DARE’s stock grew similarly to HOOK’s over the last 12 months.

DARE's P/E Growth Rating (75) in the Biotechnology industry is in the same range as HOOK (100) in the Pharmaceuticals Major industry. This means that DARE’s stock grew similarly to HOOK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DAREHOOK
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
63%
Momentum
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
83%
MACD
ODDS (%)
Bullish Trend 5 days ago
71%
Bullish Trend 5 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
76%
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 5 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 16 days ago
72%
Declines
ODDS (%)
Bearish Trend 17 days ago
82%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
88%
Aroon
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Ad is loading...
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X83102.830000617.109400
+0.75%
Bitcoin cryptocurrency
SPY536.70-27.82
-4.93%
SPDR® S&P 500® ETF Trust
TSLA267.28-15.48
-5.47%
Tesla
GME21.10-1.59
-7.01%
GameStop Corp
AAPL203.19-20.70
-9.25%
Apple

DARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, DARE has been closely correlated with RIGL. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if DARE jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DARE
1D Price
Change %
DARE100%
+0.69%
RIGL - DARE
88%
Closely correlated
-3.05%
CLNN - DARE
88%
Closely correlated
+1.67%
HOOK - DARE
87%
Closely correlated
-7.22%
PHIO - DARE
81%
Closely correlated
-3.31%
AZTR - DARE
78%
Closely correlated
-1.48%
More

HOOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOOK has been closely correlated with DARE. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if HOOK jumps, then DARE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOOK
1D Price
Change %
HOOK100%
-7.22%
DARE - HOOK
87%
Closely correlated
+0.69%
CLNN - HOOK
86%
Closely correlated
+1.67%
PHIO - HOOK
81%
Closely correlated
-3.31%
AZTR - HOOK
81%
Closely correlated
-1.48%
IMRN - HOOK
79%
Closely correlated
+2.86%
More